Search results (11)
« Back to NewsOxford team publish blueprint for making millions of doses of a new vaccine within 100 days
21 December 2021
The University of Oxford’s vaccine manufacturing research team has today published a pre-print paper demonstrating the feasibility of a step change in the speed and volume of production of adenovirus-vectored vaccines against new virus variants or other future pandemics.
New Cochrane evidence highlights uncertainty about the interventions used to prevent and treat loss of smell after COVID-19 infection
3 August 2021
Cochrane ENT at the Nuffield Department of Surgical Sciences has published two systematic reviews investigating the effectiveness and safety of interventions to prevent and treat loss of smell following COVID-19 infection.
Oxford’s researchers on the frontline
7 January 2021
We rightly hear a lot about Oxford’s vaccine, Covid-19 research and RECOVERY drug trials, but there are also countless personal stories, which display just how broad Oxford’s response to the pandemic has been. It is the contribution and commitment of many individuals that has enabled Oxford’s Medical Sciences Division to become a global leader.
Cochrane ENT awarded NIHR funding for COVID-19 project
11 December 2020
Cochrane ENT at the Nuffield Department of Surgical Sciences has been awarded funding by the National Institute for Health Research (NIHR) to complete a suite of living systematic reviews investigating the effectiveness and safety of interventions to prevent and treat loss of smell after COVID-19 infection.
First peer-reviewed results of phase 3 human trials of Oxford coronavirus vaccine demonstrate efficacy
8 December 2020
Today University of Oxford and AstraZeneca researchers present a pooled analysis of Phase 3 trials of a vaccine against SARS-CoV-2 across two different dose regimens, resulting in an average efficacy of 70.4%.
Oxford University breakthrough on global COVID-19 vaccine
23 November 2020
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.
NDS work experience goes virtual
23 July 2020
The Nuffield Department of Surgical Sciences (NDS) during lockdown launched a brand-new virtual work experience programme for students interested in pursuing a career in science and medicine.
Varying risk of COVID-19 to health workers revealed
2 July 2020
A study at Oxford University Hospitals (OUH) NHS Foundation Trust has revealed the different levels of risk faced by healthcare workers dealing with the COVID-19 pandemic.
Amazing fundraising effort supports NHS workers on COVID-19 frontline
13 May 2020
NDS’s own Dr Ying Cui has been working with the Society of Chinese Medical Practitioners and the Oxfordshire Chinese Community and Advice Centre UK to raise funds for personal protective equipment (PPE) for NHS staff.
Mr Noel Peter leads tribute to healthcare workers who lost their lives during COVID-19 pandemic
28 April 2020
Mr Noel Peter, Oxford University Global Surgery Group member and Consultant in Trauma and Orthopaedics, led the UK in a minute’s silence on Tuesday 28 April 2020 to pay tribute to all the healthcare workers who have lost their lives fighting the COVID-19 pandemic.
To the heroes of the pandemic
20 April 2020
4th year Oxford Medical School student Alex Grassam-Rowe’s writes on his admiration and respect for colleagues and others pulling together in the fight against COVID-19.